Coinciding with the release of the 2022 version of the CSCO Lymphoma Diagnosis and Treatment Guideline, Yimaitong sincerely invites Professor Zhu Jun from Peking University Cancer Hospital to interpret the updated highlights in the field of DLBCL in this guideline, and combine clinical practice to share the importance of these innovative therapies for the treatment of DLBCL.
The source of this page with content of products and services is from Internet,
which doesn't represent ECHEMI's opinion. If you have any queries, please write
to email@example.com. It will be replied within 5 days.
Moreover, if you find any instances of plagiarism from the page,
please send email to firstname.lastname@example.org with relevant evidence.